ANIP icon

ANI Pharmaceuticals

200 hedge funds and large institutions have $975M invested in ANI Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 64 increasing their positions, 54 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

0.81% less ownership

Funds ownership: 67.78%66.98% (-0.81%)

91% less call options, than puts

Call options by funds: $3.41M | Put options by funds: $39.2M

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
200
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.41M
Puts
$39.2M
Net Calls
Net Calls Change

Top Buyers

1 +$15.3M
2 +$10.4M
3 +$6.04M
4
Nuveen Asset Management
Nuveen Asset Management
Illinois
+$6M
5
Invesco
Invesco
Georgia
+$4.53M

Top Sellers

1 -$14.6M
2 -$13.3M
3 -$11.5M
4
SC
Stempoint Capital
New York
-$4.71M
5
Citadel Advisors
Citadel Advisors
Florida
-$3.82M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$175M
2
$90.3M
3
$66.3M
4
$56.8M
5
$42.1M
6
$39.7M
7
$33.9M
8
$27.8M
9
$27M
10
$23.5M
11
$22.4M
12
$17.4M
13
$17M
14
$16.8M
15
$16.1M
16
$14.8M
17
$14.5M
18
$13.6M
19
$13.3M
20
$12.5M
21
$11.3M
22
$10.4M
23
$9.39M
24
$8.21M
25
$8.18M